Press Releases
View printer-friendly version
<< Back
October 6, 2016 at 12:10 PM EDT
Flamel Technologies Reaches Agreement with FDA on Protocol for Phase III Pivotal Trial of FT218
Flamel Technologies Reaches Agreement with FDA on Protocol for Phase III Pivotal Trial of FT218